DNA damage observed in neurons treated with PR50 and iPSC-derived motor neurons from C9orf72 ALS patients is mediated by p53, indicating a complex mechanism activated by C9orf72 mutations that elicit p53 responses [85]. This evidence concerns the gene TP53 and amyotrophic lateral sclerosis.